首页 > 最新文献

Innovative Surgical Sciences最新文献

英文 中文
The discussion of risk in German surgical clinical practice guidelines: a qualitative review. 德国外科临床实践指南中风险的讨论:一项定性回顾。
IF 1.3 Q2 SURGERY Pub Date : 2021-08-25 eCollection Date: 2021-06-01 DOI: 10.1515/iss-2020-0026
Stuart McLennan, Carolin Jansen, Alena Buyx

Objectives: Clinical practice guidelines (CPGs) have a potentially important role regarding the assessment and communication of the risks of perioperative complications. This study aimed to (1) examine the content of German surgical CPGs in relation to surgical risks and (2) provide baseline results for future research in order to assess the development of surgical CPGs in Germany in relation to this issue.

Methods: In November 2015, all German surgical CPGs that provide guidance regarding illnesses that can be treated with a surgical procedure were collected from the websites of the German umbrella organisation of medical professional associations and the German Association for Cardiology.

Results: Data collection retrieved 230 CPGs of which 214 were included in the final analysis. The analysis identified four different groups: 1) 5% (10/214) of guidelines did not discuss "risks" or "complications" at all; 2) 21% (44/214) of guidelines discussed general risks that are not related to surgical complications; 3) 35% (76/214) of guidelines discussed surgical complications and often discussed their likelihood in terms of "high risk" or "low risk", but did not provide numeric estimates and 4) 39% (84/214) of guidelines discussed specific surgical risks and also provided numerical risk estimates. Guidelines with higher methodological quality more frequently included numerical risk estimates.

Conclusions: It is positive that the vast majority of German surgical CPGs address the issue of risks. However, it would be helpful if more German surgical CPGs provide explicit and evidence-based estimates and recommendations relating to the surgical risk to support surgeons in providing high-quality care and to meet their ethical obligations to patients.

目的:临床实践指南(CPGs)在评估和沟通围手术期并发症的风险方面具有潜在的重要作用。本研究旨在(1)检查德国外科CPGs的内容与手术风险的关系,(2)为未来的研究提供基线结果,以评估德国外科CPGs在这一问题上的发展。方法:2015年11月,从德国医学专业协会伞状组织和德国心脏病学协会的网站上收集了所有提供外科手术治疗疾病指导的德国外科cpg。结果:共检索到230例cpg,其中214例纳入最终分析。分析确定了四个不同的组:1)5%(10/214)的指南根本没有讨论“风险”或“并发症”;2) 21%(44/214)的指南讨论了与手术并发症无关的一般风险;3) 35%(76/214)的指南讨论了手术并发症,并经常讨论其“高风险”或“低风险”的可能性,但没有提供数字估计;4)39%(84/214)的指南讨论了具体的手术风险,也提供了数字风险估计。具有较高方法学质量的指南更经常包括数值风险估计。结论:绝大多数德国外科CPGs解决了风险问题,这是积极的。然而,如果更多的德国外科cpg提供明确的、基于证据的手术风险评估和建议,以支持外科医生提供高质量的护理,并履行他们对患者的道德义务,这将是有益的。
{"title":"The discussion of risk in German surgical clinical practice guidelines: a qualitative review.","authors":"Stuart McLennan,&nbsp;Carolin Jansen,&nbsp;Alena Buyx","doi":"10.1515/iss-2020-0026","DOIUrl":"https://doi.org/10.1515/iss-2020-0026","url":null,"abstract":"<p><strong>Objectives: </strong>Clinical practice guidelines (CPGs) have a potentially important role regarding the assessment and communication of the risks of perioperative complications. This study aimed to (1) examine the content of German surgical CPGs in relation to surgical risks and (2) provide baseline results for future research in order to assess the development of surgical CPGs in Germany in relation to this issue.</p><p><strong>Methods: </strong>In November 2015, all German surgical CPGs that provide guidance regarding illnesses that can be treated with a surgical procedure were collected from the websites of the German umbrella organisation of medical professional associations and the German Association for Cardiology.</p><p><strong>Results: </strong>Data collection retrieved 230 CPGs of which 214 were included in the final analysis. The analysis identified four different groups: 1) 5% (10/214) of guidelines did not discuss \"risks\" or \"complications\" at all; 2) 21% (44/214) of guidelines discussed general risks that are not related to surgical complications; 3) 35% (76/214) of guidelines discussed surgical complications and often discussed their likelihood in terms of \"high risk\" or \"low risk\", but did not provide numeric estimates and 4) 39% (84/214) of guidelines discussed specific surgical risks and also provided numerical risk estimates. Guidelines with higher methodological quality more frequently included numerical risk estimates.</p><p><strong>Conclusions: </strong>It is positive that the vast majority of German surgical CPGs address the issue of risks. However, it would be helpful if more German surgical CPGs provide explicit and evidence-based estimates and recommendations relating to the surgical risk to support surgeons in providing high-quality care and to meet their ethical obligations to patients.</p>","PeriodicalId":44186,"journal":{"name":"Innovative Surgical Sciences","volume":"6 2","pages":"53-57"},"PeriodicalIF":1.3,"publicationDate":"2021-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435268/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39494822","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preparing the operating room for the Covid_19 patients 为新冠肺炎患者准备手术室
IF 1.3 Q2 SURGERY Pub Date : 2021-06-01 DOI: 10.1515/iss-2021-0030
Leila Ebrahimi Sheikh Shabani, Iman Masoudi Cheleh Gahi, Samaneh Dehghan Abnavi
In December 2019, a disease called corona virus was identified in Wuhan, China, which spread rapidly around the world. The disease was first reported from seafood in Wuhan [1]. This virus belongs to the family of betacoronaviruses, which are found in abundance in nature. This Issue Creates great challenges for the prevention and treatment of Covid_19 [2]. Despite the spread of corona virus, elective surgeries have been postponed, and emergency surgeries such as trauma, complex hernias are performed with changes during surgery, including wearing personal protective clothing, and so on [3]. The indication for emergency surgery during an outbreak of coronavirus is the same as before an epidemic, but a balance between treatment time and the protection status of the treatment team against the virus is essential. However, the short time in emergency surgeries does not allow us to take PCR tests from patients before surgery, so patients should be treated like Covid_19 [4]. Necessary surgeries are defined as surgeries that cannot be delayed for more than 8 weeks because they cause disease progression and irreversible consequences. It is clear that essential and semi-essential surgeries are not always possible. Each type of surgery should be classified according to guidelines and disease status [5]. Limiting the time of cancer treatment is one of the worst cases during the Covid_19 pandemic. Also it is undeniable and has irreparable consequences. Surgery should be delayed in cancer patients with low or no advanced mass [6]. The use of a special room and a separate anesthesia machine for the patient is necessary during the pandemic. If anesthesia requires medication during induction, the hands should be disinfected first and the gloves replaced. Personnel should remove their used gloves and disinfect their hands At the end of the surgery. Minimal equipment and tools should be used in the operating room and all equipment and tools used should not be taken out of the operating room and should be disposed of in a special container. It should be taken at least 1 h betweenpatients to disinfect surfaces and equipment. The operating room should be disinfected with hydrogen peroxide. In general, there is evidence that using of PPE canminimize the risk of disease transmission and protect personnel. In conclusion, health care workers are at high risk of contracting the coronavirus. Comprehensive infection control is essential to prevent this infection.
2019年12月,一种名为冠状病毒的疾病在中国武汉被发现,并在全球迅速传播。该疾病最初是在武汉的海鲜中报告的。这种病毒属于在自然界中大量存在的冠状病毒家族。这一问题给防治新冠肺炎带来了巨大挑战。尽管冠状病毒传播,选择性手术仍被推迟,创伤、复杂疝气等紧急手术在手术过程中进行了改变,包括穿个人防护服等b[3]。冠状病毒爆发期间的急诊手术指征与疫情前相同,但在治疗时间和治疗团队对病毒的保护状态之间取得平衡至关重要。但是,由于紧急手术时间较短,无法在手术前对患者进行PCR检测,因此应该像对待covid - 19一样对待患者。必要手术被定义为不能延迟超过8周的手术,因为它们会导致疾病进展和不可逆转的后果。很明显,必要和半必要的手术并不总是可能的。每种类型的手术应根据指南和疾病状况进行分类。限制癌症治疗时间是新冠肺炎大流行期间最严重的情况之一。而且,它是不可否认的,并具有不可弥补的后果。低或无晚期肿块bbb的癌症患者应延迟手术。在大流行期间,有必要为病人使用特殊的房间和单独的麻醉机。如果在诱导过程中需要麻醉药物,应先消毒双手并更换手套。操作人员应在手术结束时摘掉用过的手套并对双手进行消毒。手术室应尽量减少设备和工具的使用,所有使用的设备和工具不得带出手术室,并应放置在专用容器中。患者之间对表面和设备进行消毒应至少间隔1小时。手术室应用双氧水消毒。总的来说,有证据表明,使用个人防护装备可以最大限度地减少疾病传播的风险并保护人员。总之,医护人员感染冠状病毒的风险很高。全面的感染控制对预防这种感染至关重要。
{"title":"Preparing the operating room for the Covid_19 patients","authors":"Leila Ebrahimi Sheikh Shabani, Iman Masoudi Cheleh Gahi, Samaneh Dehghan Abnavi","doi":"10.1515/iss-2021-0030","DOIUrl":"https://doi.org/10.1515/iss-2021-0030","url":null,"abstract":"In December 2019, a disease called corona virus was identified in Wuhan, China, which spread rapidly around the world. The disease was first reported from seafood in Wuhan [1]. This virus belongs to the family of betacoronaviruses, which are found in abundance in nature. This Issue Creates great challenges for the prevention and treatment of Covid_19 [2]. Despite the spread of corona virus, elective surgeries have been postponed, and emergency surgeries such as trauma, complex hernias are performed with changes during surgery, including wearing personal protective clothing, and so on [3]. The indication for emergency surgery during an outbreak of coronavirus is the same as before an epidemic, but a balance between treatment time and the protection status of the treatment team against the virus is essential. However, the short time in emergency surgeries does not allow us to take PCR tests from patients before surgery, so patients should be treated like Covid_19 [4]. Necessary surgeries are defined as surgeries that cannot be delayed for more than 8 weeks because they cause disease progression and irreversible consequences. It is clear that essential and semi-essential surgeries are not always possible. Each type of surgery should be classified according to guidelines and disease status [5]. Limiting the time of cancer treatment is one of the worst cases during the Covid_19 pandemic. Also it is undeniable and has irreparable consequences. Surgery should be delayed in cancer patients with low or no advanced mass [6]. The use of a special room and a separate anesthesia machine for the patient is necessary during the pandemic. If anesthesia requires medication during induction, the hands should be disinfected first and the gloves replaced. Personnel should remove their used gloves and disinfect their hands At the end of the surgery. Minimal equipment and tools should be used in the operating room and all equipment and tools used should not be taken out of the operating room and should be disposed of in a special container. It should be taken at least 1 h betweenpatients to disinfect surfaces and equipment. The operating room should be disinfected with hydrogen peroxide. In general, there is evidence that using of PPE canminimize the risk of disease transmission and protect personnel. In conclusion, health care workers are at high risk of contracting the coronavirus. Comprehensive infection control is essential to prevent this infection.","PeriodicalId":44186,"journal":{"name":"Innovative Surgical Sciences","volume":"32 1","pages":"87 - 88"},"PeriodicalIF":1.3,"publicationDate":"2021-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74054564","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cohort study of the overall survival of patients with pancreatic cancer in a hospital of specialties of Quito-Ecuador in the period 2007–2017 基多-厄瓜多尔某专科医院2007-2017年胰腺癌患者总生存期的队列研究
IF 1.3 Q2 SURGERY Pub Date : 2021-05-03 DOI: 10.1515/iss-2020-0030
Andrés Moreno Roca, L. Armijos Acurio, R. Jimbo Sotomayor, Carlos Céspedes Rivadeneira, Carlos Rosero Reyes, Carlos López Ayala
Abstract Objectives Pancreatic cancers in most patients in Ecuador are diagnosed at an advanced stage of the disease, which is associated with lower survival. To determine the characteristics and global survival of pancreatic cancer patients in a social security hospital in Ecuador between 2007 and 2017. Methods A retrospective cohort study and a survival analysis were performed using all the available data in the electronic clinical records of patients with a diagnosis of pancreatic cancer in a Hospital of Specialties of Quito-Ecuador between 2007 and 2017. The included patients were those coded according to the ICD 10 between C25.0 and C25.9. Our univariate analysis calculated frequencies, measures of central tendency and dispersion. Through the Kaplan-Meier method we estimated the median time of survival and analyzed the difference in survival time among the different categories of our included variables. These differences were shown through the log rank test. Results A total of 357 patients diagnosed with pancreatic cancer between 2007 and 2017 were included in the study. More than two-thirds (69.9%) of the patients were diagnosed in late stages of the disease. The median survival time for all patients was of 4 months (P25: 2, P75: 8). Conclusions The statistically significant difference of survival time between types of treatment is the most relevant finding in this study, when comparing to all other types of treatments.
在厄瓜多尔,大多数胰腺癌患者被诊断为胰腺癌晚期,这与较低的生存率相关。确定2007年至2017年厄瓜多尔一家社会保障医院胰腺癌患者的特征和总体生存率。方法利用基多-厄瓜多尔一家专科医院2007年至2017年诊断为胰腺癌的患者的电子临床记录中所有可获得的数据进行回顾性队列研究和生存分析。纳入的患者是根据ICD 10在C25.0到C25.9之间进行编码的患者。我们的单变量分析计算了频率、集中趋势和分散的度量。通过Kaplan-Meier法估计中位生存时间,并分析不同类别纳入变量的生存时间差异。这些差异是通过对数秩检验来显示的。结果在2007年至2017年期间,共有357名诊断为胰腺癌的患者被纳入研究。超过三分之二(69.9%)的患者被诊断为疾病晚期。所有患者的中位生存时间均为4个月(P25: 2, P75: 8)。结论与所有其他治疗方式相比,不同治疗方式的生存时间差异具有统计学意义,这是本研究中最相关的发现。
{"title":"Cohort study of the overall survival of patients with pancreatic cancer in a hospital of specialties of Quito-Ecuador in the period 2007–2017","authors":"Andrés Moreno Roca, L. Armijos Acurio, R. Jimbo Sotomayor, Carlos Céspedes Rivadeneira, Carlos Rosero Reyes, Carlos López Ayala","doi":"10.1515/iss-2020-0030","DOIUrl":"https://doi.org/10.1515/iss-2020-0030","url":null,"abstract":"Abstract Objectives Pancreatic cancers in most patients in Ecuador are diagnosed at an advanced stage of the disease, which is associated with lower survival. To determine the characteristics and global survival of pancreatic cancer patients in a social security hospital in Ecuador between 2007 and 2017. Methods A retrospective cohort study and a survival analysis were performed using all the available data in the electronic clinical records of patients with a diagnosis of pancreatic cancer in a Hospital of Specialties of Quito-Ecuador between 2007 and 2017. The included patients were those coded according to the ICD 10 between C25.0 and C25.9. Our univariate analysis calculated frequencies, measures of central tendency and dispersion. Through the Kaplan-Meier method we estimated the median time of survival and analyzed the difference in survival time among the different categories of our included variables. These differences were shown through the log rank test. Results A total of 357 patients diagnosed with pancreatic cancer between 2007 and 2017 were included in the study. More than two-thirds (69.9%) of the patients were diagnosed in late stages of the disease. The median survival time for all patients was of 4 months (P25: 2, P75: 8). Conclusions The statistically significant difference of survival time between types of treatment is the most relevant finding in this study, when comparing to all other types of treatments.","PeriodicalId":44186,"journal":{"name":"Innovative Surgical Sciences","volume":"21 1","pages":"75 - 79"},"PeriodicalIF":1.3,"publicationDate":"2021-05-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89854247","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
German oncology certification system for colorectal cancer - relative survival rates of a single certified centre vs. national and international registry data. 德国结直肠癌肿瘤认证系统-单个认证中心与国家和国际注册数据的相对存活率。
IF 1.3 Q2 SURGERY Pub Date : 2021-04-30 eCollection Date: 2021-06-01 DOI: 10.1515/iss-2021-0002
Maximilian Richter, Lena Sonnow, Amir Mehdizadeh-Shrifi, Axel Richter, Rainer Koch, Alexander Zipprich

Objectives: To evaluate how the certification of specialised Oncology Centres in Germany affects the relative survival of patients with colorectal cancer (CRC) by means of national and international comparison.

Methods: Between 2007 and 2013, 675 patients with colorectal cancer, treated at the Hildesheim Hospital, an academic teaching hospital of the Hannover Medical School (MHH), were included. A follow-up of the entire patient group was performed until 2014. To obtain international data, a SEER-database search was done. The relative survival of 148,957 patients was compared to our data after 12, 36 and 60 months. For national survival data, we compared our rates with 41,988 patients of the Munich Cancer Registry (MCR).

Results: Relative survival at our institution tends to be higher in advanced tumour stages compared to national and international cancer registry data. Nationally we found only little variation in survival rates for low stages CRC (UICC I and II), colon, and rectal cancer. There were notable variations regarding relative survival rates for advanced CRC tumour stages (UICC IV). These variations were even more distinct for rectal cancer after 12, 36 and 60 months (Hildesheim Hospital: 89.9, 40.3, 30.1%; Munich Cancer Registry (MCR): 65.4, 28.7, 16.6%). The international comparison of CRC showed significantly higher relative survival rates for patients with advanced tumour stages after 12 months at our institution (77 vs. 54.9% for UICC IV; raw p<0.001).

Conclusions: Our findings suggest that patients with advanced tumour stages of CRC and especially rectal cancer benefit most from a multidisciplinary and guidelines-oriented treatment at Certified Oncology Centres. For a better evaluation of cancer treatment and improved national and international comparison, the creation of a centralised national cancer registry is necessary.

目的:通过国内和国际比较,评估德国专业肿瘤中心的认证如何影响结直肠癌(CRC)患者的相对生存。方法:2007年至2013年,在汉诺威医学院(MHH)的学术教学医院希尔德斯海姆医院(Hildesheim Hospital)接受治疗的675例结直肠癌患者。整个患者组的随访一直持续到2014年。为了获得国际数据,进行了seer数据库检索。148,957例患者在12个月、36个月和60个月后的相对生存率与我们的数据进行了比较。对于国家生存数据,我们将我们的生存率与慕尼黑癌症登记处(MCR)的41988名患者进行了比较。结果:与国内和国际癌症登记数据相比,我们机构的肿瘤晚期相对生存率更高。在全国范围内,我们发现低期CRC (UICC I和II)、结肠癌和直肠癌的生存率变化很小。晚期结直肠癌肿瘤分期(UICC IV)的相对生存率存在显著差异,直肠癌在12个月、36个月和60个月后的相对生存率差异更为明显(Hildesheim医院:89.9、40.3、30.1%;慕尼黑癌症登记处(MCR): 65.4, 28.7, 16.6%)。CRC的国际比较显示,在我们的机构,晚期肿瘤患者在12个月后的相对生存率显著更高(77% vs. 54.9%;结论:我们的研究结果表明,晚期结直肠癌患者尤其是直肠癌患者从认证肿瘤中心的多学科和指南导向治疗中获益最多。为了更好地评估癌症治疗并改进国内和国际比较,有必要建立一个集中的国家癌症登记处。
{"title":"German oncology certification system for colorectal cancer - relative survival rates of a single certified centre vs. national and international registry data.","authors":"Maximilian Richter,&nbsp;Lena Sonnow,&nbsp;Amir Mehdizadeh-Shrifi,&nbsp;Axel Richter,&nbsp;Rainer Koch,&nbsp;Alexander Zipprich","doi":"10.1515/iss-2021-0002","DOIUrl":"https://doi.org/10.1515/iss-2021-0002","url":null,"abstract":"<p><strong>Objectives: </strong>To evaluate how the certification of specialised Oncology Centres in Germany affects the relative survival of patients with colorectal cancer (CRC) by means of national and international comparison.</p><p><strong>Methods: </strong>Between 2007 and 2013, 675 patients with colorectal cancer, treated at the Hildesheim Hospital, an academic teaching hospital of the Hannover Medical School (MHH), were included. A follow-up of the entire patient group was performed until 2014. To obtain international data, a SEER-database search was done. The relative survival of 148,957 patients was compared to our data after 12, 36 and 60 months. For national survival data, we compared our rates with 41,988 patients of the Munich Cancer Registry (MCR).</p><p><strong>Results: </strong>Relative survival at our institution tends to be higher in advanced tumour stages compared to national and international cancer registry data. Nationally we found only little variation in survival rates for low stages CRC (UICC I and II), colon, and rectal cancer. There were notable variations regarding relative survival rates for advanced CRC tumour stages (UICC IV). These variations were even more distinct for rectal cancer after 12, 36 and 60 months (Hildesheim Hospital: 89.9, 40.3, 30.1%; Munich Cancer Registry (MCR): 65.4, 28.7, 16.6%). The international comparison of CRC showed significantly higher relative survival rates for patients with advanced tumour stages after 12 months at our institution (77 vs. 54.9% for UICC IV; raw p<0.001).</p><p><strong>Conclusions: </strong>Our findings suggest that patients with advanced tumour stages of CRC and especially rectal cancer benefit most from a multidisciplinary and guidelines-oriented treatment at Certified Oncology Centres. For a better evaluation of cancer treatment and improved national and international comparison, the creation of a centralised national cancer registry is necessary.</p>","PeriodicalId":44186,"journal":{"name":"Innovative Surgical Sciences","volume":"6 2","pages":"67-73"},"PeriodicalIF":1.3,"publicationDate":"2021-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1515/iss-2021-0002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39494824","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Clinical and scientific advances in neurosurgery. 神经外科的临床和科学进展。
IF 1.3 Q2 SURGERY Pub Date : 2021-04-27 eCollection Date: 2021-03-01 DOI: 10.1515/iss-2021-2037
Gabriele Schackert, Tareq A Juratli
This special issue is dedicated to clinical and scientific advances in neurosurgery. It provides insights in the broad spectrum of neurosurgery, spanning topics from the peripheral neuromodulation in paretic patients, to special aspects in the management of skull base tumors as well as advances in the treatment of the degenerative spine. Finally, an outlook on experimental immunotherapeutic strategies, explaining the principles of vaccine-based immunotherapy in brain tumors, is presented. Two original articles deal with recent advances in neurosurgical techniques. The spastic drop foot, caused after stroke or during the course of multiple sclerosis (MS), limits the patients’ quality of life in a significant dimension. Martin et al. present long-term results after implantation of the ActiGait system—an implantable peroneal nerve stimulation—at 36-month follow-up. The study includes 27 stroke and six multiple sclerosis patients. Selective electrical stimulation was applied to the fascicles of the peroneal nerve through a four-channel cuff electrode proximal to the knee joint, which contracts the ankle dorsiflexor and everter muscles followed by a balanced dorsiflexion of the foot. Patients have been assessed for gait endurance, speed, risk of fall and quality of life at baseline and 36 months following implantation. Most of the patients reported remarkable improvements of their walking abilities and especially of their daily quality of life. These results highlight the long-lasting effect of the ActiGait system as an effective treatment of the spastic drop foot. Thedegenerative spine disease is awidespreaddisease with an enormous impact on the professional, the economic, and the social life. Therefore, in the second original article we focused on innovations in spine surgery. Salchow-Gille et al. undertook a study, in which they evaluated software-based pre-surgical simulation effects on device selection and device development. Based on video-fluoroscopic motion recordings and pixel-precise processing of the segmental motion patterns, a softwarebased surrogate functionalmodelwas tested. 253 randomly selected patients, requiring single-level cervical or lumbar implant, were included in the study. Based on the described software-surrogate, the authors concluded that individualized devices might decelerate degeneration of adjacent segments by influencing the intersegmental communication of the motion segments and subsequently improve patient’s outcome. Tumor surgery is one of the main domains in neurosurgery. We selected for this issue the special problems in craniopharyngioma treatment, which combines several medical disciplines e.g. endocrinology, ophthalmology, and neurosurgery. As in all brain tumor surgeries, the preservation of the neurological functions is the primary goal. The special challenge in craniopharyngioma surgery is the additional preservation of endocrine and visual functions. Fujio et al. discuss in their original article two compe
{"title":"Clinical and scientific advances in neurosurgery.","authors":"Gabriele Schackert,&nbsp;Tareq A Juratli","doi":"10.1515/iss-2021-2037","DOIUrl":"https://doi.org/10.1515/iss-2021-2037","url":null,"abstract":"This special issue is dedicated to clinical and scientific advances in neurosurgery. It provides insights in the broad spectrum of neurosurgery, spanning topics from the peripheral neuromodulation in paretic patients, to special aspects in the management of skull base tumors as well as advances in the treatment of the degenerative spine. Finally, an outlook on experimental immunotherapeutic strategies, explaining the principles of vaccine-based immunotherapy in brain tumors, is presented. Two original articles deal with recent advances in neurosurgical techniques. The spastic drop foot, caused after stroke or during the course of multiple sclerosis (MS), limits the patients’ quality of life in a significant dimension. Martin et al. present long-term results after implantation of the ActiGait system—an implantable peroneal nerve stimulation—at 36-month follow-up. The study includes 27 stroke and six multiple sclerosis patients. Selective electrical stimulation was applied to the fascicles of the peroneal nerve through a four-channel cuff electrode proximal to the knee joint, which contracts the ankle dorsiflexor and everter muscles followed by a balanced dorsiflexion of the foot. Patients have been assessed for gait endurance, speed, risk of fall and quality of life at baseline and 36 months following implantation. Most of the patients reported remarkable improvements of their walking abilities and especially of their daily quality of life. These results highlight the long-lasting effect of the ActiGait system as an effective treatment of the spastic drop foot. Thedegenerative spine disease is awidespreaddisease with an enormous impact on the professional, the economic, and the social life. Therefore, in the second original article we focused on innovations in spine surgery. Salchow-Gille et al. undertook a study, in which they evaluated software-based pre-surgical simulation effects on device selection and device development. Based on video-fluoroscopic motion recordings and pixel-precise processing of the segmental motion patterns, a softwarebased surrogate functionalmodelwas tested. 253 randomly selected patients, requiring single-level cervical or lumbar implant, were included in the study. Based on the described software-surrogate, the authors concluded that individualized devices might decelerate degeneration of adjacent segments by influencing the intersegmental communication of the motion segments and subsequently improve patient’s outcome. Tumor surgery is one of the main domains in neurosurgery. We selected for this issue the special problems in craniopharyngioma treatment, which combines several medical disciplines e.g. endocrinology, ophthalmology, and neurosurgery. As in all brain tumor surgeries, the preservation of the neurological functions is the primary goal. The special challenge in craniopharyngioma surgery is the additional preservation of endocrine and visual functions. Fujio et al. discuss in their original article two compe","PeriodicalId":44186,"journal":{"name":"Innovative Surgical Sciences","volume":"6 1","pages":"1-2"},"PeriodicalIF":1.3,"publicationDate":"2021-04-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1515/iss-2021-2037","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39860548","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tumor visualization and fluorescence angiography with indocyanine green (ICG) in laparoscopic and robotic hepatobiliary surgery - valuation of early adopters from Germany. 肿瘤可视化和荧光血管造影与吲哚菁绿(ICG)在腹腔镜和机器人肝胆手术-评估早期采用者来自德国。
IF 1.3 Q2 SURGERY Pub Date : 2021-04-22 eCollection Date: 2021-06-01 DOI: 10.1515/iss-2020-0019
Mareike Franz, Jörg Arend, Stefanie Wolff, Aristotelis Perrakis, Mirhasan Rahimli, Victor-Radu Negrini, Jessica Stockheim, Eric Lorenz, Roland Croner

Objectives: Indocyanine green (ICG) is a fluorescent dye which was initially used for liver functional assessment. Moreover, it is of value for intraoperative visualization of liver segments and bile ducts or primary and secondary liver tumors. Especially in minimally invasive liver surgery, this is essential to enhance the precision of anatomical guided surgery and oncological quality. As early adopters of ICG implementation into laparoscopic and robotic-assisted liver surgery in Germany, we summarize the current recommendations and share our experiences.

Methods: Actual strategies for ICG application in minimally invasive liver surgery were evaluated and summarized during a review of the literature. Experiences in patients who underwent laparoscopic or robotic-assisted liver surgery with intraoperative ICG staining between 2018 and 2020 from the Magdeburg registry for minimally invasive liver surgery (MD-MILS) were evaluated and the data were analyzed retrospectively.

Results: ICG can be used to identify anatomical liver segments by fluorescence angiography via direct or indirect tissue staining. Fluorescence cholangiography visualizes the intra- and extrahepatic bile ducts. Primary and secondary liver tumors can be identified with a sensitivity of 69-100%. For this 0.5 mg/kg body weight ICG must be applicated intravenously 2-14 days prior to surgery. Within the MD-MILS we identified 18 patients which received ICG for intraoperative tumor staining of hepatocellular carcinoma (HCC), cholangiocarcinoma, peritoneal HCC metastases, adenoma, or colorectal liver metastases. The sensitivity for tumor staining was 100%. In 27.8% additional liver tumors were identified by ICG fluorescence. In 39% a false positive signal could be detected. This occurred mainly in cirrhotic livers.

Conclusions: ICG staining is a simple and useful tool to assess individual hepatic anatomy or to detect tumors during minimally invasive liver surgery. It may enhance surgical precision and improve oncological quality. False-positive detection rates of liver tumors can be reduced by respecting the tumor entity and liver functional impairments.

目的:吲哚菁绿(ICG)是一种荧光染料,最初用于肝功能评估。此外,它对术中肝段、胆管或原发性、继发性肝脏肿瘤的显像也有价值。特别是在微创肝脏手术中,这对于提高解剖引导手术的精度和肿瘤质量至关重要。作为德国腹腔镜和机器人辅助肝脏手术中ICG实施的早期采用者,我们总结了目前的建议并分享了我们的经验。方法:通过文献回顾,对ICG在肝脏微创手术中的实际应用策略进行评价和总结。对马格德堡微创肝脏手术登记处(MD-MILS) 2018年至2020年期间接受腹腔镜或机器人辅助肝脏手术的患者进行术中ICG染色的经验进行评估,并对数据进行回顾性分析。结果:ICG可通过直接或间接组织染色,通过荧光血管造影识别解剖肝段。荧光胆管造影显示肝内和肝外胆管。原发性和继发性肝脏肿瘤的识别灵敏度为69-100%。对于0.5 mg/kg体重的ICG,必须在手术前2-14天静脉应用。在MD-MILS中,我们确定了18例接受ICG术中肿瘤染色的肝细胞癌(HCC)、胆管癌、腹膜HCC转移、腺瘤或结直肠肝转移患者。肿瘤染色敏感性为100%。另外27.8%的肝脏肿瘤可通过ICG荧光检测出来。在39%中可以检测到假阳性信号。这主要发生在肝硬化。结论:ICG染色是评估个体肝脏解剖或在微创肝脏手术中发现肿瘤的一种简单而有用的工具。可提高手术精度,提高肿瘤质量。尊重肿瘤实体和肝功能损害,可降低肝脏肿瘤的假阳性检出率。
{"title":"Tumor visualization and fluorescence angiography with indocyanine green (ICG) in laparoscopic and robotic hepatobiliary surgery - valuation of early adopters from Germany.","authors":"Mareike Franz,&nbsp;Jörg Arend,&nbsp;Stefanie Wolff,&nbsp;Aristotelis Perrakis,&nbsp;Mirhasan Rahimli,&nbsp;Victor-Radu Negrini,&nbsp;Jessica Stockheim,&nbsp;Eric Lorenz,&nbsp;Roland Croner","doi":"10.1515/iss-2020-0019","DOIUrl":"https://doi.org/10.1515/iss-2020-0019","url":null,"abstract":"<p><strong>Objectives: </strong>Indocyanine green (ICG) is a fluorescent dye which was initially used for liver functional assessment. Moreover, it is of value for intraoperative visualization of liver segments and bile ducts or primary and secondary liver tumors. Especially in minimally invasive liver surgery, this is essential to enhance the precision of anatomical guided surgery and oncological quality. As early adopters of ICG implementation into laparoscopic and robotic-assisted liver surgery in Germany, we summarize the current recommendations and share our experiences.</p><p><strong>Methods: </strong>Actual strategies for ICG application in minimally invasive liver surgery were evaluated and summarized during a review of the literature. Experiences in patients who underwent laparoscopic or robotic-assisted liver surgery with intraoperative ICG staining between 2018 and 2020 from the Magdeburg registry for minimally invasive liver surgery (MD-MILS) were evaluated and the data were analyzed retrospectively.</p><p><strong>Results: </strong>ICG can be used to identify anatomical liver segments by fluorescence angiography via direct or indirect tissue staining. Fluorescence cholangiography visualizes the intra- and extrahepatic bile ducts. Primary and secondary liver tumors can be identified with a sensitivity of 69-100%. For this 0.5 mg/kg body weight ICG must be applicated intravenously 2-14 days prior to surgery. Within the MD-MILS we identified 18 patients which received ICG for intraoperative tumor staining of hepatocellular carcinoma (HCC), cholangiocarcinoma, peritoneal HCC metastases, adenoma, or colorectal liver metastases. The sensitivity for tumor staining was 100%. In 27.8% additional liver tumors were identified by ICG fluorescence. In 39% a false positive signal could be detected. This occurred mainly in cirrhotic livers.</p><p><strong>Conclusions: </strong>ICG staining is a simple and useful tool to assess individual hepatic anatomy or to detect tumors during minimally invasive liver surgery. It may enhance surgical precision and improve oncological quality. False-positive detection rates of liver tumors can be reduced by respecting the tumor entity and liver functional impairments.</p>","PeriodicalId":44186,"journal":{"name":"Innovative Surgical Sciences","volume":"6 2","pages":"59-66"},"PeriodicalIF":1.3,"publicationDate":"2021-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1515/iss-2020-0019","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39494823","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 16
The future of scientific publication is Open Access, but needs diversity, equability and equality! 科学出版的未来是开放获取,但需要多样性、公平性和平等性!
IF 1.3 Q2 SURGERY Pub Date : 2021-04-07 eCollection Date: 2021-06-01 DOI: 10.1515/iss-2021-2038
Joachim Jähne
{"title":"The future of scientific publication is Open Access, but needs diversity, equability and equality!","authors":"Joachim Jähne","doi":"10.1515/iss-2021-2038","DOIUrl":"10.1515/iss-2021-2038","url":null,"abstract":"","PeriodicalId":44186,"journal":{"name":"Innovative Surgical Sciences","volume":"6 2","pages":"49-51"},"PeriodicalIF":1.3,"publicationDate":"2021-04-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435267/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39494820","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prospective surgical solutions in degenerative spine: spinal simulation for optimal choice of implant and targeted device development. 前瞻性手术解决方案退行性脊柱:脊柱模拟的最佳选择植入物和目标装置的发展。
IF 1.3 Q2 SURGERY Pub Date : 2021-04-07 eCollection Date: 2021-03-01 DOI: 10.1515/iss-2019-1002
Monique Salchow-Gille, Bernhard Rieger, Clemens Reinshagen, Marek Molcanyi, Joschka Lemke, Uta Brautferger, Kerim Hakan Sitoci-Ficici, Witold Polanski, Thomas Pinzer, Gabriele Schackert

Objectives: The most important goal of surgical treatment for spinal degeneration, in addition to eliminating the underlying pathology, is to preserve the biomechanically relevant structures. If degeneration destroys biomechanics, the single segment must either be surgically stabilized or functionally replaced by prosthetic restoration. This study examines how software-based presurgical simulation affects device selection and device development.

Methods: Based on videofluoroscopic motion recordings and pixel-precise processing of the segmental motion patterns, a software-based surrogate functional model was validated. It characterizes the individual movement of spinal segments relative to corresponding cervical or lumbar spine sections. The single segment-based motion of cervical or lumbar spine of individual patients can be simulated, if size-calibrated functional X-rays of the relevant spine section are available. The software plug-in "biokinemetric triangle" has been then integrated into this software to perform comparative segmental motion analyses before and after treatment in two cervical device studies: the correlation of implant-induced changes in the movement geometry and patient-related outcome was examined to investigate, whether this surrogate model could provide a guideline for implant selection and future implant development.

Results: For its validation in 253 randomly selected patients requiring single-level cervical (n=122) or lumbar (n=131) implant-supported restoration, the biokinemetric triangle provided significant pattern recognition in comparable investigations (p<0.05) and the software detected device-specific changes after implant-treatment (p<0.01). Subsequently, 104 patients, who underwent cervical discectomy, showed a correlation of the neck disability index with implant-specific changes in their segmental movement geometry: the preoperative simulation supported the best choice of surgical implants, since the best outcome resulted from restricting the extent of the movement of adjacent segments influenced by the technical mechanism of the respective device (p<0.05).

Conclusions: The implant restoration resulted in best outcome which modified intersegmental communication in a way that the segments adjacent to the implanted segment undergo less change in their own movement geometry. Based on our software-surrogate, individualized devices could be created that slow down further degeneration of adjacent segments by influencing the intersegmental communication of the motion segments.

目的:脊柱退变手术治疗的最重要目标,除了消除潜在病理外,是保护生物力学相关结构。如果退变破坏了生物力学,单个节段必须通过手术稳定或用假体修复代替。本研究探讨了基于软件的术前模拟如何影响设备选择和设备开发。方法:基于视频透视运动记录和像素精确处理的节段运动模式,验证了基于软件的代理功能模型。它描述了脊柱节段相对于相应的颈椎或腰椎节段的个体运动。如果有相关脊柱部分的尺寸校准功能x光片,则可以模拟个体患者颈椎或腰椎的单节段运动。然后将软件插件“生物运动三角”集成到该软件中,在两项颈椎器械研究中对治疗前后的节段运动进行比较分析:检查植入物引起的运动几何变化与患者相关结果的相关性,以探讨该替代模型是否可以为植入物的选择和未来植入物的开发提供指导。结果:在253例随机选择的需要单节段颈椎(n=122)或腰椎(n=131)种植体支持修复的患者中进行验证,生物运动三角形在可比研究中提供了显著的模式识别(结论:种植体修复的最佳结果是通过改变种植体相邻节段的运动几何变化来改变节段间的通信。基于我们的软件替代,可以创建个性化的设备,通过影响运动节段之间的通信来减缓相邻节段的进一步退化。
{"title":"Prospective surgical solutions in degenerative spine: spinal simulation for optimal choice of implant and targeted device development.","authors":"Monique Salchow-Gille,&nbsp;Bernhard Rieger,&nbsp;Clemens Reinshagen,&nbsp;Marek Molcanyi,&nbsp;Joschka Lemke,&nbsp;Uta Brautferger,&nbsp;Kerim Hakan Sitoci-Ficici,&nbsp;Witold Polanski,&nbsp;Thomas Pinzer,&nbsp;Gabriele Schackert","doi":"10.1515/iss-2019-1002","DOIUrl":"https://doi.org/10.1515/iss-2019-1002","url":null,"abstract":"<p><strong>Objectives: </strong>The most important goal of surgical treatment for spinal degeneration, in addition to eliminating the underlying pathology, is to preserve the biomechanically relevant structures. If degeneration destroys biomechanics, the single segment must either be surgically stabilized or functionally replaced by prosthetic restoration. This study examines how software-based presurgical simulation affects device selection and device development.</p><p><strong>Methods: </strong>Based on videofluoroscopic motion recordings and pixel-precise processing of the segmental motion patterns, a software-based surrogate functional model was validated. It characterizes the individual movement of spinal segments relative to corresponding cervical or lumbar spine sections. The single segment-based motion of cervical or lumbar spine of individual patients can be simulated, if size-calibrated functional X-rays of the relevant spine section are available. The software plug-in \"biokinemetric triangle\" has been then integrated into this software to perform comparative segmental motion analyses before and after treatment in two cervical device studies: the correlation of implant-induced changes in the movement geometry and patient-related outcome was examined to investigate, whether this surrogate model could provide a guideline for implant selection and future implant development.</p><p><strong>Results: </strong>For its validation in 253 randomly selected patients requiring single-level cervical (n=122) or lumbar (n=131) implant-supported restoration, the biokinemetric triangle provided significant pattern recognition in comparable investigations (p<0.05) and the software detected device-specific changes after implant-treatment (p<0.01). Subsequently, 104 patients, who underwent cervical discectomy, showed a correlation of the neck disability index with implant-specific changes in their segmental movement geometry: the preoperative simulation supported the best choice of surgical implants, since the best outcome resulted from restricting the extent of the movement of adjacent segments influenced by the technical mechanism of the respective device (p<0.05).</p><p><strong>Conclusions: </strong>The implant restoration resulted in best outcome which modified intersegmental communication in a way that the segments adjacent to the implanted segment undergo less change in their own movement geometry. Based on our software-surrogate, individualized devices could be created that slow down further degeneration of adjacent segments by influencing the intersegmental communication of the motion segments.</p>","PeriodicalId":44186,"journal":{"name":"Innovative Surgical Sciences","volume":"6 1","pages":"11-24"},"PeriodicalIF":1.3,"publicationDate":"2021-04-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1515/iss-2019-1002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39771828","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Endoscopic negative pressure therapy (ENPT) of a spontaneous oesophageal rupture (Boerhaave's syndrome) with peritonitis - a new treatment option. 内镜负压疗法(ENPT)治疗自发性食管破裂(Boerhaave综合征)合并腹膜炎-一种新的治疗选择。
IF 1.3 Q2 SURGERY Pub Date : 2021-04-06 eCollection Date: 2021-06-01 DOI: 10.1515/iss-2020-0043
Gunnar Loske, Katrin Albers, Christian T Mueller

Objectives: Boerhaave's syndrome is a life-threatening disease with high mortality and morbidity. Endoscopic negative pressure therapy (ENPT) can be used to treat oesophageal perforations.

Case presentation: We report on a case of oesophageal rupture with peritonitis in a 35-year-old male patient. The start of treatment was 11 h after the perforation event. The treatment of the perforation defect was performed exclusively by intraluminal ENPT, the treatment of peritonitis was performed by laparotomy with abdominal lavage. For ENPT we used two different types of open-pore drains. The first treatment cycle of four days was performed with an open-pored polyurethane foam drainage (OPD), which was placed intraluminal to cover the perforation defect and to empty the stomach permanently. The second treatment cycle of nine days was performed with a thin nasogastric tube like double-lumen open-pored film drainage (OFD). For suction OPD and OFD were connected with an electronic vacuum pump (-125 mmHg). OFD enables active gastric emptying with simultaneous intestinal feeding via an integrated feeding tube. Intraluminal ENPT with a total treatment duration of 13 days was able to achieve the complete healing of the defect. Surgical treatment of the perforation defect was not necessary. The patient was discharged 20 days after initial treatment with a non-irritating abdominal wound and a closed perforation.

Conclusions: In suitable cases, endoscopic negative pressure therapy is a minimally invasive, organ-preserving procedure for the treatment of spontaneous oesophageal rupture.

目的:布尔哈夫综合征是一种死亡率和发病率高、危及生命的疾病。内镜下负压疗法(ENPT)可用于治疗食管穿孔。病例介绍:我们报告一例食道破裂并腹膜炎的病例在一个35岁的男性病人。在穿孔事件发生后11小时开始治疗。穿孔缺损的治疗完全采用腔内ENPT,腹膜炎的治疗采用开腹洗腹。对于ENPT,我们使用了两种不同类型的开孔引流。第一个治疗周期为4天,使用开孔聚氨酯泡沫引流管(OPD),将其放置在腔内以覆盖穿孔缺陷并永久排空胃。第二个治疗周期为9天,采用薄鼻胃管式双腔开孔膜引流(OFD)。抽吸时,将OPD和OFD与电子真空泵(-125 mmHg)连接。OFD使胃排空与同时肠道喂养通过一个集成的喂食管。腔内ENPT总治疗时间为13天,缺损完全愈合。穿孔缺损不需要手术治疗。患者在初次治疗20天后出院,腹部无刺激性伤口和闭合穿孔。结论:在合适的病例中,内镜负压治疗是一种微创的、保留器官的治疗方法。
{"title":"Endoscopic negative pressure therapy (ENPT) of a spontaneous oesophageal rupture (Boerhaave's syndrome) with peritonitis - a new treatment option.","authors":"Gunnar Loske,&nbsp;Katrin Albers,&nbsp;Christian T Mueller","doi":"10.1515/iss-2020-0043","DOIUrl":"https://doi.org/10.1515/iss-2020-0043","url":null,"abstract":"<p><strong>Objectives: </strong>Boerhaave's syndrome is a life-threatening disease with high mortality and morbidity. Endoscopic negative pressure therapy (ENPT) can be used to treat oesophageal perforations.</p><p><strong>Case presentation: </strong>We report on a case of oesophageal rupture with peritonitis in a 35-year-old male patient. The start of treatment was 11 h after the perforation event. The treatment of the perforation defect was performed exclusively by intraluminal ENPT, the treatment of peritonitis was performed by laparotomy with abdominal lavage. For ENPT we used two different types of open-pore drains. The first treatment cycle of four days was performed with an open-pored polyurethane foam drainage (OPD), which was placed intraluminal to cover the perforation defect and to empty the stomach permanently. The second treatment cycle of nine days was performed with a thin nasogastric tube like double-lumen open-pored film drainage (OFD). For suction OPD and OFD were connected with an electronic vacuum pump (-125 mmHg). OFD enables active gastric emptying with simultaneous intestinal feeding via an integrated feeding tube. Intraluminal ENPT with a total treatment duration of 13 days was able to achieve the complete healing of the defect. Surgical treatment of the perforation defect was not necessary. The patient was discharged 20 days after initial treatment with a non-irritating abdominal wound and a closed perforation.</p><p><strong>Conclusions: </strong>In suitable cases, endoscopic negative pressure therapy is a minimally invasive, organ-preserving procedure for the treatment of spontaneous oesophageal rupture.</p>","PeriodicalId":44186,"journal":{"name":"Innovative Surgical Sciences","volume":"6 2","pages":"81-86"},"PeriodicalIF":1.3,"publicationDate":"2021-04-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1515/iss-2020-0043","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39494825","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Prospects of immune checkpoint blockade and vaccine-based immunotherapy for glioblastoma 免疫检查点阻断和基于疫苗的免疫治疗胶质母细胞瘤的前景
IF 1.3 Q2 SURGERY Pub Date : 2021-03-01 DOI: 10.1515/iss-2020-0034
Stefanie Tietze, Susanne Michen, G. Schackert, A. Temme
Abstract Glioblastoma multiforme (GBM) is the most prevalent primary brain tumor endowed with a dismal prognosis. Nowadays, immunotherapy in a particular immune checkpoint blockade and therapeutic vaccines are being extensively pursued. Yet, several characteristics of GBM may impact such immunotherapeutic approaches. This includes tumor heterogeneity, the relatively low mutational load of primary GBM, insufficient delivery of antibodies to tumor parenchyma and the unique immunosuppressive microenvironment of GBM. Moreover, standard treatment of GBM, comprising temozolomide chemotherapy, radiotherapy and in most instances the application of glucocorticoids for management of brain edema, results in a further increased immunosuppression. This review will provide a brief introduction to the principles of vaccine-based immunotherapy and give an overview of the current clinical studies, which employed immune checkpoint inhibitors, oncolytic viruses-based vaccination, cell-based and peptide-based vaccines. Recent experiences as well as the latest developments are reviewed. Overcoming obstacles, which limit the induction and long-term immune response against GBM when using vaccination approaches, are necessary for the implementation of effective immunotherapy of GBM.
多形性胶质母细胞瘤(GBM)是最常见的原发性脑肿瘤,预后较差。目前,免疫治疗在一个特定的免疫检查点封锁和治疗性疫苗被广泛追求。然而,GBM的几个特征可能会影响这种免疫治疗方法。这包括肿瘤异质性、原发性GBM相对较低的突变负荷、抗体对肿瘤实质的递送不足以及GBM独特的免疫抑制微环境。此外,GBM的标准治疗,包括替莫唑胺化疗、放射治疗和在大多数情况下应用糖皮质激素治疗脑水肿,导致免疫抑制进一步增加。本文将简要介绍基于疫苗的免疫治疗原理,并对目前的临床研究进行综述,包括免疫检查点抑制剂、溶瘤病毒疫苗、细胞疫苗和肽疫苗。回顾了最近的经验和最新的发展。克服使用疫苗接种方法时限制GBM诱导和长期免疫应答的障碍,是实现GBM有效免疫治疗的必要条件。
{"title":"Prospects of immune checkpoint blockade and vaccine-based immunotherapy for glioblastoma","authors":"Stefanie Tietze, Susanne Michen, G. Schackert, A. Temme","doi":"10.1515/iss-2020-0034","DOIUrl":"https://doi.org/10.1515/iss-2020-0034","url":null,"abstract":"Abstract Glioblastoma multiforme (GBM) is the most prevalent primary brain tumor endowed with a dismal prognosis. Nowadays, immunotherapy in a particular immune checkpoint blockade and therapeutic vaccines are being extensively pursued. Yet, several characteristics of GBM may impact such immunotherapeutic approaches. This includes tumor heterogeneity, the relatively low mutational load of primary GBM, insufficient delivery of antibodies to tumor parenchyma and the unique immunosuppressive microenvironment of GBM. Moreover, standard treatment of GBM, comprising temozolomide chemotherapy, radiotherapy and in most instances the application of glucocorticoids for management of brain edema, results in a further increased immunosuppression. This review will provide a brief introduction to the principles of vaccine-based immunotherapy and give an overview of the current clinical studies, which employed immune checkpoint inhibitors, oncolytic viruses-based vaccination, cell-based and peptide-based vaccines. Recent experiences as well as the latest developments are reviewed. Overcoming obstacles, which limit the induction and long-term immune response against GBM when using vaccination approaches, are necessary for the implementation of effective immunotherapy of GBM.","PeriodicalId":44186,"journal":{"name":"Innovative Surgical Sciences","volume":"34 1","pages":"35 - 48"},"PeriodicalIF":1.3,"publicationDate":"2021-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81984387","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
期刊
Innovative Surgical Sciences
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1